You must log in to view this page.

RespireRx Pharmaceuticals Inc

OTC: RSPI
Share price (5/31/24): $0.00
Market cap (5/31/24): $2.655 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

Late annual filing notification for FY 2023

ended 09/30/23 Q3

Late quarterly filing notification for Q3 2023

ended 06/30/23 Q2

Late quarterly filing notification for Q2 2023

Prospectuses and Registrations Filter

Changes or additions to offering circular

Changes or additions to offering circular

Changes or additions to offering circular

Changes or additions to offering circular

Changes or additions to offering circular

Ownership Filter

Jones Timothy L.

MacFarlane Katie

News Filter

Announces a Department of Defense Award to Fund a Phase 2 Clinical Study to Determine the Safety and Efficacy of CX1739, Its Lead AMPAkine, to Improve Bladder Function in Patients With Spinal Cord Injury

Material Definitive Agreement, Financial Statements or Exhibits

Material Definitive Agreement, Financial Statements or Exhibits

Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors

Announces Agreement With Ponto Ventures to Drive Business Development With Will Clodfelter as RespireRx Part-Time Senior VP of Business Development

Proxies Filter

Definitive proxy

Preliminary revised proxy

Preliminary proxy

Preliminary info

Other Filter

Correspondence with the SEC

Letter from the SEC

Letter from the SEC

Notice of effectiveness